At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As Business Insider and other outlets report, Kardashian Barker's brand Lemme has launched a new line of oral supplements marketed as an alternative to actual glucagon-like peptide-1 drugs like Ozempic and Wegovy.

Boasted as being a “breakthrough capsule formula designed to boost GLP-1 hormone levels, reduce hunger and cravings and support healthy weight management,” the supplement contains three clinically-studied, patented ingredients: Eriomin® Lemon Fruit Extract, Supresa® Saffron Extract, and Morosil™ Red Orange Fruit Extract.

Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other GLP-1s, such as semaglutide, the active ingredient in Ozempic. A rapid drop in weight can result in a loss of bone density,

Bre Teamer chats with Dr. Alex Zayid of Icon Anti-Aging about recent developments and research that supports using Alzheimer's as a tool to treat Alzheimer's.